Russell AS - Search Results

1

Targeting tumour necrosis factor alleviates signs and symptoms of inflammatory osteoarthritis of the knee.

Maksymowych WP, Russell AS, Chiu P, Yan A, Jones N, Clare T, Lambert RG. Maksymowych WP, et al. Among authors: russell as. Arthritis Res Ther. 2012 Oct 4;14(5):R206. doi: 10.1186/ar4044. Arthritis Res Ther. 2012. PMID: 23036475 Free PMC article. Clinical Trial.

2

A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis.

Maksymowych WP, Jhangri GS, Fitzgerald AA, LeClercq S, Chiu P, Yan A, Skeith KJ, Aaron SL, Homik J, Davis P, Sholter D, Russell AS. Maksymowych WP, et al. Among authors: russell as. Arthritis Rheum. 2002 Mar;46(3):766-73. doi: 10.1002/art.10139. Arthritis Rheum. 2002. PMID: 11920413 Free article. Clinical Trial.

3

Anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis treated with anti-tumour necrosis factor agents.

Russell AS, Maksymowych WP, de Silva M. Russell AS, et al. Ann Rheum Dis. 2005 Dec;64(12):1807. doi: 10.1136/ard.2005.040436. Ann Rheum Dis. 2005. PMID: 16284357 Free PMC article. No abstract available.

4

Canadian Rheumatology Association Consensus on the use of anti-tumor necrosis factor-alpha directed therapies in the treatment of spondyloarthritis.

Maksymowych WP, Inman RD, Gladman D, Thomson G, Stone M, Karsh J, Russell AS; Spondyloarthritis Research Consortium of Canada (SPARCC). Maksymowych WP, et al. Among authors: russell as. J Rheumatol. 2003 Jun;30(6):1356-63. J Rheumatol. 2003. PMID: 12784417 Review.

5

The dosage of infliximab in the treatment of ankylosing spondylitis: dollars and sense.

Russell AS, Orozco JH, Maksymowych WP. Russell AS, et al. Clin Exp Rheumatol. 2002 Nov-Dec;20(6 Suppl 28):S135-6. Clin Exp Rheumatol. 2002. PMID: 12463464

6

Infliximab in ankylosing spondylitis: a prospective observational inception cohort analysis of efficacy and safety.

Maksymowych WP, Jhangri GS, Lambert RG, Mallon C, Buenviaje H, Pedrycz E, Luongo R, Russell AS. Maksymowych WP, et al. Among authors: russell as. J Rheumatol. 2002 May;29(5):959-65. J Rheumatol. 2002. PMID: 12022358 Clinical Trial.

7

The responsiveness of generic health status measures as assessed in patients with rheumatoid arthritis receiving infliximab.

Russell AS, Conner-Spady B, Mintz A, Maksymowych WP. Russell AS, et al. J Rheumatol. 2003 May;30(5):941-7. J Rheumatol. 2003. PMID: 12734886

8

Prospective observational analysis of the efficacy and safety of low-dose (3 mg/kg) infliximab in ankylosing spondylitis: 4-year followup.

Keeling S, Oswald A, Russell AS, Maksymowych WP. Keeling S, et al. Among authors: russell as. J Rheumatol. 2006 Mar;33(3):558-61. Epub 2006 Feb 1. J Rheumatol. 2006. PMID: 16463437 Clinical Trial.

9

Development and validation of the Edmonton Ankylosing Spondylitis Metrology Index.

Maksymowych WP, Mallon C, Richardson R, Conner-Spady B, Jauregui E, Chung C, Zappala L, Pile K, Russell AS. Maksymowych WP, et al. Among authors: russell as. Arthritis Rheum. 2006 Aug 15;55(4):575-82. doi: 10.1002/art.22103. Arthritis Rheum. 2006. PMID: 16874779 Free article.

10

Canadian estimates of health care utilization costs for rheumatoid arthritis patients with and without therapy with biologic agents.

Ohinmaa AE, Thanh NX, Barnabe C, Martin L, Russell AS, Barr SG, Maksymowych WP. Ohinmaa AE, et al. Among authors: russell as. Arthritis Care Res (Hoboken). 2014 Sep;66(9):1319-27. doi: 10.1002/acr.22293. Arthritis Care Res (Hoboken). 2014. PMID: 24470178 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

438 results

Search Page

Filters